Table 1

 Demographic distribution of study participants, proportion with spirometric data at visit 6 (approximately 4 years after baseline visit), and the proportion of subjects in the most rapidly declining quartile of FEV1 or FEV1/FVC ratio. From the Cardiovascular Health Study (CHS) 1989–90 and follow up through visit 6

Baseline (N = 4923)Follow up (N = 3338)
N (%)% without spirometry at follow upRisk of no spirometry at follow up OR (95% CI)*N (%)% in most rapid FEV1 decline quartileRisk of being in most rapid FEV1 decline quartile OR (95% CI)*
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; BMI, body mass index; OR, odds ratio; CI, confidence interval.
*Adjusted for age, sex, race, smoking status, body mass index, education level, depression, diabetes, cardiovascular disease, exercise level, and GOLD category.
†GOLD stage 3 or 4 (FEV1/FVC <0.70 and FEV1 <50% predicted), GOLD stage 2 (FEV1/FVC <0.70 and FEV1 ⩾50% to <80% predicted), GOLD stage 1 (FEV1/FVC <0.70 and FEV1 ⩾80%), restricted (FEV1/FVC ⩾0.70 and FVC <80% predicted), GOLD stage 0 (presence of respiratory symptoms in the absence of any lung function abnormality), and no lung disease.
Age group
    65–731282 (26.0)21.41.01007 (29.7)22.61.0
    74–771470 (29.9)25.51.2 (1.0 to 1.5)1095 (32.3)25.31.2 (0.98 to 1.5)
    78–81975 (19.8)31.41.6 (1.3 to 2.0)669 (19.8)25.11.2 (0.9 to 1.5)
    82–85695 (14.1)40.32.1 (1.7 to 2.7)415 (12.3)28.21.3 (1.01 to 1.7)
    86+501 (10.2)59.74.9 (3.9 to 6.3)202 (6.0)24.81.2 (0.8 to 1.7)
Sex
    Female2780 (56.5)29.91.0 (0.8 to 1.1)1949 (57.5)26.91.4 (1.2 to 1.6)
    Male2143 (43.5)32.81.01439 (42.5)22.01.0
Race
    White4695 (95.4)30.71.03254 (96.0)24.71.0
    Black228 (4.6)41.21.3 (0.9 to 1.7)134 (4.0)27.61.0 (0.7 to 1.5)
Smoking status
    Current smoker571 (11.6)35.51.4 (1.1 to 1.7)368 (10.9)37.81.8 (1.4 to 2.3)
    Former smoker2100 (42.7)31.31.1 (1.0 to 1.3)1442 (42.6)23.21.1 (0.9 to 1.3)
    Never smoker2252 (45.7)29.91.01578 (46.6)23.21.0
BMI (kg/m2)
    <20225 (4.6)39.61.4 (1.0 to 1.9)136 (4.0)31.61.2 (0.8 to 1.7)
    21–241765 (35.9)31.31.01213 (35.8)26.11.0
    25–292057 (41.8)29.60.9 (0.8 to 1.0)1449 (42.8)23.30.9 (0.8 to 1.1)
    ⩾30876 (17.8)32.61.0 (0.8 to 1.2)590 (17.4)24.10.9 (0.7 to 1.2)
Education level
    <12 years1352 (27.5)41.21.7 (1.4 to 2.0)795 (23.5)28.11.2 (1.0 to 1.5)
    12 years1397 (28.4)30.41.4 (1.2 to 1.6)972 (28.7)24.41.0 (0.9 to 1.3)
    >12 years2174 (44.2)25.41.01621 (47.8)23.41.0
Depressed
    Yes1197 (24.3)39.81.4 (1.2 to 1.6)720 (21.2)26.41.0 (0.8 to 1.2)
    No3726 (75.7)28.41.02668 (78.8)24.41.0
Diabetes
    Yes1422 (28.9)37.71.4 (1.2 to 1.7)2502 (73.9)23.10.9 (0.7 to 1.1)
    No3501 (71.1)28.51.0886 (26.1)25.41.0
Cardiovascular disease
    Yes1060 (21.5)42.61.5 (1.3 to 1.8)608 (18.0)27.11.2 (0.96 to 1.4)
    No3863 (78.5)28.01.02780 (82.0)24.31.0
Exercise level
    Lowest482 (9.8)50.82.1 (1.7 to 2.6)237 (7.0)29.51.3 (0.9 to 1.8)
    2888 (18.0)40.61.8 (1.5 to 2.1)527 (15.6)26.61.2 (0.9 to 1.5)
    31492 (30.3)30.01.2 (1.1 to 1.4)1045 (30.8)27.11.2 (1.03 to 1.5)
    Highest2061 (41.9)23.41.01579 (46.6)22.01.0
GOLD category†
    GOLD 3 or 4330 (6.7)47.32.1 (1.6 to 2.8)174 (5.1)28.21.3 (0.9 to 1.9)
    GOLD 2962 (19.5)35.81.3 (1.1 to 1.6)618 (18.2)31.71.6 (1.2 to 2.0)
    GOLD 1782 (15.9)30.71.2 (0.96 to 1.5)542 (16.0)23.41.1 (0.8 to 1.4)
    GOLD 0981 (19.9)30.01.6 (1.2 to 2.0)687 (20.3)23.81.2 (0.9 to 1.7)
    Restricted510 (10.4)39.41.2 (0.9 to 1.4)309 (9.1)25.91.1 (0.8 to 1.3)
    Normal1358 (27.6)22.11.01058 (31.2)21.31.0
Total492331.2338824.8